Business Syre Therapeutics inventory worth goal raised to $106 by Leerink Last updated: April 13, 2026 7:35 pm Editor Published: April 13, 2026 Share Syre Therapeutics inventory worth goal raised to $106 by Leerink Analyst Report: Axon Enterprise Inc Sumitomo Mitsui Belief Financial institution, HPC accomplice to broaden different investments in Japan GN Retailer Nord initiates 2026 outlook, shares rise on sturdy money move LARRY KUDLOW: Democratic makes an attempt to sabotage the Trump increase are failing miserably Dwell Nation reaches settlement with DOJ in antitrust case Sign Up For Daily NewsletterBe keep up! Get the latest breaking news delivered straight to your inbox.[mc4wp_form]By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. Share This Article Facebook Email Copy Link Print Previous Article Right here’s How This Impacts Worth Restoration Probabilities Next Article Proof Builds: The AI Increase Stays Intact Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Follow USFind US on Socials FacebookLikeXFollowYoutubeSubscribeTelegramFollow Popular News Cerebras Inventory Falls Beneath $185 IPO Value Amid GPT-6.1 Nvidia-GPU Declare June 2026 Work Progress: New Pearl Pool, Zcash Hardfork, and Two Delistings OpenSea to Assist Arc From Day One among Mainnet Launch
